#Netherlands #Leiden #Ultima Genomics #BaseClear #UG200 Platform

Ultima Genomics and BaseClear Team Up for High-Throughput Sequencing in Europe

In a groundbreaking alliance, Ultima Genomics and BaseClear B.V. have announced their plan to enhance accessibility to low-cost, high-throughput sequencing solutions throughout Europe. This strategic partnership marks BaseClear as the first Ultima Certified Service Provider on the continent, utilizing Ultima's state-of-the-art UG200 platform.

Ultima Genomics has been at the forefront of genomic technology development, aiming to transform the landscape of data-intensive applications through its innovative sequencing solutions. The UG200 platform, in particular, is designed to provide a scalable and economical alternative for researchers and companies operating in fields like cell and gene therapy, vaccine development, and industrial biotechnology.

BaseClear is well-regarded for its extensive expertise in genomics, lab automation, and bioinformatics, making it the ideal candidate to bring this cutting-edge sequencing technology to a wider audience. The partnership promises a completely automated workflow that encompasses every stage of the genomic analysis process—from sample receipt and genomic extraction to library preparation, sequencing, and data delivery.

This collaboration is especially timely as it builds on prior agreements, particularly BaseClear’s selection by Basecamp Research to aid in creating a Trillion Gene Atlas. This ambitious project aims to generate and model biological data at an unprecedented scale, further demonstrating the growing demand for sequencing technologies that can keep up with expansive biological inquiries.

Gilad Almogy from Ultima Genomics emphasizes the importance of this partnership in an era where large-scale biological discoveries hinge on the capacity to generate high-quality genomic data efficiently. He remarked, “BaseClear's scientific expertise and services infrastructure make them an important partner as we enhance access to sequencing technologies.”

Roel Sterken, CEO of BaseClear, echoed these sentiments, stating, “By integrating Ultima’s UG200 Platform into our service offerings, we provide a potent option for clients with projects that require high scale, data integrity, and cost efficiency.” With the collaborative effort of both companies, researchers can tap into the vast potential of genomics, fostering quicker and more informed decision-making algorithms aimed at patient therapies.

Launched in mid-July 2026, BaseClear’s Ultima-enabled services are set to revolutionize access to genomic information across various sectors, from clinical research to pharmaceuticals. With the unprecedented capabilities presented by Ultima's UG200 platform, scientific and economic boundaries in genomics are being redefined.

For more information on BaseClear’s Ultima-enabled services, you can visit BaseClear's website.

Both companies are excited about the future and the possibilities that this partnership holds. As they move forward, the collaboration aims not only to streamline research capabilities but also to accelerate the availability of innovative therapies to the patients who need them most. The impact of their combined efforts is expected to resonate throughout the genomics field well into the future.